These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16913720)

  • 1. Phosphonothioate and fluoromethylene phosphonate analogues of cyclic phosphatidic acid: Novel antagonists of lysophosphatidic acid receptors.
    Xu Y; Jiang G; Tsukahara R; Fujiwara Y; Tigyi G; Prestwich GD
    J Med Chem; 2006 Aug; 49(17):5309-15. PubMed ID: 16913720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Darmstoff analogs as selective agonists and antagonists of lysophosphatidic acid receptors.
    Gududuru V; Zeng K; Tsukahara R; Makarova N; Fujiwara Y; Pigg KR; Baker DL; Tigyi G; Miller DD
    Bioorg Med Chem Lett; 2006 Jan; 16(2):451-6. PubMed ID: 16290140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantioselective responses to a phosphorothioate analogue of lysophosphatidic acid with LPA3 receptor-selective agonist activity.
    Qian L; Xu Y; Hasegawa Y; Aoki J; Mills GB; Prestwich GD
    J Med Chem; 2003 Dec; 46(26):5575-8. PubMed ID: 14667211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and pharmacological evaluation of second-generation phosphatidic acid derivatives as lysophosphatidic acid receptor ligands.
    Durgam GG; Tsukahara R; Makarova N; Walker MD; Fujiwara Y; Pigg KR; Baker DL; Sardar VM; Parrill AL; Tigyi G; Miller DD
    Bioorg Med Chem Lett; 2006 Feb; 16(3):633-40. PubMed ID: 16263282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of cyclic phosphonate analogues of (lyso)phosphatidic acid using a ring-closing metathesis reaction.
    Zhang H; Tsukuhara R; Tigyi G; Prestwich GD
    J Org Chem; 2006 Aug; 71(16):6061-6. PubMed ID: 16872189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARgamma, and inhibitors of autotaxin.
    Durgam GG; Virag T; Walker MD; Tsukahara R; Yasuda S; Liliom K; van Meeteren LA; Moolenaar WH; Wilke N; Siess W; Tigyi G; Miller DD
    J Med Chem; 2005 Jul; 48(15):4919-30. PubMed ID: 16033271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.
    Ohta H; Sato K; Murata N; Damirin A; Malchinkhuu E; Kon J; Kimura T; Tobo M; Yamazaki Y; Watanabe T; Yagi M; Sato M; Suzuki R; Murooka H; Sakai T; Nishitoba T; Im DS; Nochi H; Tamoto K; Tomura H; Okajima F
    Mol Pharmacol; 2003 Oct; 64(4):994-1005. PubMed ID: 14500756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorothioate analogues of alkyl lysophosphatidic acid as LPA3 receptor-selective agonists.
    Qian L; Xu Y; Simper T; Jiang G; Aoki J; Umezu-Goto M; Arai H; Yu S; Mills GB; Tsukahara R; Makarova N; Fujiwara Y; Tigyi G; Prestwich GD
    ChemMedChem; 2006 Mar; 1(3):376-83. PubMed ID: 16892372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques.
    Rother E; Brandl R; Baker DL; Goyal P; Gebhard H; Tigyi G; Siess W
    Circulation; 2003 Aug; 108(6):741-7. PubMed ID: 12885756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of fluorinated lysophosphatidic acid analogues.
    Xu Y; Aoki J; Shimizu K; Umezu-Goto M; Hama K; Takanezawa Y; Yu S; Mills GB; Arai H; Qian L; Prestwich GD
    J Med Chem; 2005 May; 48(9):3319-27. PubMed ID: 15857137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial structure-activity relationships of lysophosphatidic acid receptor antagonists: discovery of a high-affinity LPA1/LPA3 receptor antagonist.
    Heasley BH; Jarosz R; Lynch KR; Macdonald TL
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2735-40. PubMed ID: 15125924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective blockade of lysophosphatidic acid LPA3 receptors reduces murine renal ischemia-reperfusion injury.
    Okusa MD; Ye H; Huang L; Sigismund L; Macdonald T; Lynch KR
    Am J Physiol Renal Physiol; 2003 Sep; 285(3):F565-74. PubMed ID: 12770838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of mTOR signaling by novel fluoromethylene phosphonate analogues of phosphatidic acid.
    Xu Y; Fang Y; Chen J; Prestwich GD
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1461-4. PubMed ID: 15006382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid.
    Altman MK; Gopal V; Jia W; Yu S; Hall H; Mills GB; McGinnis AC; Bartlett MG; Jiang G; Madan D; Prestwich GD; Xu Y; Davies MA; Murph MM
    Mol Cancer; 2010 Jun; 9():140. PubMed ID: 20529378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin.
    Khandoga AL; Fujiwara Y; Goyal P; Pandey D; Tsukahara R; Bolen A; Guo H; Wilke N; Liu J; Valentine WJ; Durgam GG; Miller DD; Jiang G; Prestwich GD; Tigyi G; Siess W
    Platelets; 2008 Sep; 19(6):415-27. PubMed ID: 18925509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel series of 2-pyridyl-containing compounds as lysophosphatidic acid receptor antagonists: development of a nonhydrolyzable LPA3 receptor-selective antagonist.
    Heasley BH; Jarosz R; Carter KM; Van SJ; Lynch KR; Macdonald TL
    Bioorg Med Chem Lett; 2004 Aug; 14(15):4069-74. PubMed ID: 15225728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alkyl lysophosphatidic acid and fluoromethylene phosphonate analogs as metabolically-stabilized agonists for LPA receptors.
    Xu Y; Tanaka M; Arai H; Aoki J; Prestwich GD
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5323-8. PubMed ID: 15454220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of migration-resistant hydroxyethoxy analogues of lysophosphatidic acid.
    Qian L; Xu Y; Arai H; Aoki J; McIntyre TM; Prestwich GD
    Org Lett; 2003 Nov; 5(24):4685-8. PubMed ID: 14627415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of aberrant DNA methylation on reduced expression of lysophosphatidic acid receptor-1 gene in rat tumor cell lines.
    Tsujiuchi T; Shimizu K; Onishi M; Sugata E; Fujii H; Mori T; Honoki K; Fukushima N
    Biochem Biophys Res Commun; 2006 Oct; 349(3):1151-5. PubMed ID: 16970915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a phosphothionate analogue of lysophosphatidic acid (LPA) as a selective agonist of the LPA3 receptor.
    Hasegawa Y; Erickson JR; Goddard GJ; Yu S; Liu S; Cheng KW; Eder A; Bandoh K; Aoki J; Jarosz R; Schrier AD; Lynch KR; Mills GB; Fang X
    J Biol Chem; 2003 Apr; 278(14):11962-9. PubMed ID: 12554733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.